HIGHLIGHTS
- who: Tomer Meirson from the (UNIVERSITY) have published the Article: Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology, in the Journal: (JOURNAL)
- what: In this using existing clinical trial data and FDA approvals the authors propose that there is currently a critical need for an appropriate balancing between the financial impact of new cancer drugs and their actual benefit for patients.
- how: Currently the authors are seeing the rapid identification of potential targets and emergence of multiple novel therapies that are tested . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.